Skip to main content
. 2022 Dec;10(24):1371. doi: 10.21037/atm-22-6045

Table 1. Basic characteristics of trunk melanoma patients in the training and internal validation cohorts.

Factors Define Train (n=14,841) Test (n=6,357) All (n=21,198)
Age (years) 59.89±15.64 60.02±15.49 59.93±15.60
Marriage Married 10,296 (69.38) 4,484 (70.54) 14,780 (69.72)
Divorced 2,503 (16.87) 1,005 (15.81) 3,508 (16.55)
Single 890 (6.00) 388 (6.10) 1,278 (6.03)
Other 1,152 (7.76) 480 (7.55) 1,632 (7.70)
Race White 14,700 (99.05) 6,304 (99.17) 21,004 (99.08)
Other 141 (0.95) 53 (0.83) 194 (0.92)
Sex Male 10,141 (68.33) 4,308 (67.77) 14,449 (68.16)
Female 4,700 (31.67) 2,049 (32.23) 6,749 (31.84)
Laterality Left 6,034 (40.66) 2,692 (42.35) 8,726 (41.16)
Right 5,807 (39.13) 2,374 (37.34) 8,181 (38.59)
Bilateral 3,000 (20.21) 1,291 (20.31) 4,291 (20.24)
Behavior Behav1 6,735 (45.38) 2,840 (44.68) 9,575 (45.17)
Behav2 5,836 (39.32) 2,542 (39.99) 8,378 (39.52)
Behav3 2,270 (15.30) 975 (15.34) 3,245 (15.31)
Stage I 11,353 (76.50) 4,852 (76.33) 16,205 (76.45)
II 1,906 (12.84) 847 (13.32) 2,753 (12.99)
III 1,386 (9.34) 597 (9.39) 1,983 (9.35)
IV 196 (1.32) 61 (0.96) 257 (1.21)
T T1 9,859 (66.43) 4,233 (66.59) 14,092 (66.48)
T2 2,511 (16.92) 1,044 (16.42) 3,555 (16.77)
T3 1,368 (9.22) 598 (9.41) 1,966 (9.27)
T4 1,103 (7.43) 482 (7.58) 1,585 (7.48)
N N0 14,213 (95.77) 6,103 (96.00) 20,316 (95.84)
N1 408 (2.75) 187 (2.94) 595 (2.81)
N2 220 (1.48) 67 (1.05) 287 (1.35)
Surgery Surg1 7,935 (53.47) 3,445 (54.19) 11,380 (53.68)
Surg2 5,621 (37.87) 2,420 (38.07) 8,041 (37.93)
Surg3 217 (1.46) 88 (1.38) 305 (1.44)
Surg4 1,068 (7.20) 404 (6.36) 1,472 (6.94)
LNSur None 6,276 (42.29) 2,718 (42.76) 8,994 (42.43)
1–3 5,825 (39.25) 2,509 (39.47) 8,334 (39.32)
4+ 339 (2.28) 130 (2.04) 469 (2.21)
Others 2,401 (16.18) 1,000 (15.73) 3,401 (16.04)
SurgOth None 9,158 (61.71) 3,901 (61.37) 13,059 (61.60)
Yes 5,683 (38.29) 2,456 (38.63) 8,139 (38.40)
Radiation No 14,677 (98.89) 6,267 (98.58) 20,944 (98.80)
Yes 164 (1.11) 90 (1.42) 254 (1.20)
Chemotherapy No 14,605 (98.41) 6,272 (98.66) 20,877 (98.49)
Yes 236 (1.59) 85 (1.34) 321 (1.51)
Breslow 0.7 [0.4, 1.4] 0.7 [0.4, 1.3] 0.7 [0.4, 1.4]
Pretreatment LDH Other 13,288 (89.54) 5,696 (89.60) 18,984 (89.56)
Normal level 1,112 (7.49) 444 (6.98) 1,556 (7.34)
Above 441 (2.97) 217 (3.41) 658 (3.10)
Ulceration No 12,626 (85.08) 5,427 (85.37) 18,053 (85.16)
Yes 2,215 (14.92) 930 (14.63) 3,145 (14.84)
Mitotic 0 [0, 2] 0 [0, 2] 0 [0, 2]
Positive No 2,404 (16.20) 1,018 (16.01) 3,422 (16.14)
Yes 6,220 (41.91) 2,653 (41.73) 8,873 (41.86)
Other 6,217 (41.89) 2,686 (42.25) 8,903 (42.00)
Bone No 14,790 (99.66) 6,343 (99.78) 21,133 (99.69)
Yes 51 (0.34) 14 (0.22) 65 (0.31)
Brain No 14,791 (99.66) 6,340 (99.73) 21,131 (99.68)
Yes 50 (0.34) 17 (0.27) 67 (0.32)
Liver No 14,788 (99.64) 6,344 (99.80) 21,132 (99.69)
Yes 53 (0.36) 13 (0.20) 66 (0.31)
Lung No 14,758 (99.44) 6,333 (99.62) 21,091 (99.50)
Yes 83 (0.56) 24 (0.38) 107 (0.50)
Malignant 1 9,378 (63.19) 4,004 (62.99) 13,382 (63.13)
>1 5,463 (36.81) 2,353 (37.01) 7,816 (36.87)
Status 0 12,167 (81.98) 5,217 (82.07) 17,384 (82.01)
1 1,204 (8.11) 505 (7.94) 1,709 (8.06)
2 1,470 (9.90) 635 (9.99) 2,105 (9.93)
Time (years) 59.34±24.96 59.19±24.75 59.30±24.90

Data are present as n (%), median [range], or mean ± SD. LNSur, LN surgery; LN, lymph node; SurgOth, surgery other; LDH, lactate dehydrogenase; SD, standard deviation.